Summary: A method was developed for the simultaneous determination of hypoxanthine, xanthine, uric acid and allantoin based on isocratic reversed-phase chromatography. This HPLC-method additionally allows the direct determination with UV-detection of inosine-5'-phosphate, uridine, thymine, orotic acid, allopurinol and oxipurinol, besides hypoxanthine, xanthine and uric acid in the same Chromatographie run. Allantoin elutes in this system near the void volume and a fraction is collected covering the retention time range for this substance. After hydrolysis allantoin is converted to glyoxylate-2,4-dinitrophenylhydrazone, rechromatographed and detected at 360 nm.
Introduction 0 ι * j· u u c Λ * Ŝ everal studies have been performed to assess the The myocytes as well as the vascular endothelial cells relevance of purine metabolism in ischemic tissue of the heart are both targets for damage by free (2-4), but no attempt has been made to determine" radicals generated during myocardial ischemia and the metabolites arising from the action of xanthine reperfusion. A possibly important process for the oxido-reductase on allantoin, the product resulting generation of oxygen radicals is the conversion of from the oxidation of uric acid by free oxygen radihypoxanthine to xanthine and finally uric acid by the cals. The function of uric acid as an antioxidant in enzyme xanthine oxido-reductase (EC 1.2.3.2) local-vitro has been shown for several targets of free radical ized in the endothelial cell. Normally this enzyme action (5-7); furthermore, it has been shown that reduces NAD 4 " and does not form free oxygen radi-the concentration of allantoin is elevated in synovia cals, but it has been shown by McCord et al. (1) , that and serum of rheumatoid patients (8) . this enzyme is converted during ischemia to the oxi- TT x , . . . t. ι ι Γ -Here we report the optimization of an HPLC method dase form, which uses molecular oxygen as an όχι-,. ι · , · r i_ j ·*· <-,. . * · * j rxTA-rn-terminal metabolites of purine metabolism including "non-physiological" allantoin. Reference ranges were assessed for hypoxanthine, xanthine, uric acid and allantoin.
Materials and Methods

Chemicals
Allantoin, allopurinol, hyoxanthine, inosine-5'-phosphate, orotic acid, oxipurinol, thymine, uridine and xanthine were obtained from SIGMA, Munich, Germany in the highest available grade of purity and used for preparation of the standard solutions. Uric acid was Standard Reference Material with a purity of 99.7% (SRM 913, National Bureau of Standards, Washington D. C. 20234). All other chemicals were purchased from Merck (Darmstadt, Germany) and were of analytical grade; methanol was HPLC-grade. Demineralized water was prepared with a Milli-Q apparatus from Millipore GmbH (Eschborn, Germany). The control material for the uric acid determination was Standard Reference Material (Human Serum SRM 909, National Bureau of Standards, Washington D. C. 20234).
Samples
The serum samples for the reference range assessment were from healthy blood donors. The Sarstedt system with separation gel was used for withdrawn blood, and the time between blood withdrawal and centrifugation never exceeded 30 min.
and uridine were dissolved in demineralized water. Allopurinol, hypoxanthine, oxipurinol, thymine and xanthine were dissolved in 0.1 mol/1 NaOH, and uric acid was dissolved in 0.013 mol/1 NH 3 .
Preparation of the standard mixture for the solvent system optimization
For every pH the standard mixture was prepared from the stock-standards separately. A solution consisting of 1 ml of each stock-standard (total volume 11 ml) was mixed with 9 ml solvent B to give a final volume of 20 ml. The concentrations of each constituent in the standard mixture was 25 μιηοΐ/ΐ. An aliquot (50 μΐ) of this standard mixture, containing 1.25 nmpl of each component, was injected for the determination of the retention times.
Preparation of the standards for the determination of hypoxanthine, xanthine, uric acid and allantoin in serum
Stock-standards of hypoxanthine, xanthine and allantoin (1 ml of each) were mixed with 20 ml of the stock-standard of uric acid and diluted with solvent C to 50 ml in a volumetric flask. This standard, which contained 10 μπιοΐ/l hypoxanthine, xanthine and allantoin and 200 μηιοΐ/ΐ uric acid, was diluted to produce a calibration curve covering the range from 25 prnol to 500 pmol injected hypoxanthine, xanthine and allantoin. Uric acid was injected to produce a range between 0.5 nmol and 100 nmol. Hypoxanthine was detected at a wavelength of 248 nm, xanthine at 264 nm, and uric acid at 285 iim. The calibration was based on the areas calculated with the Waters PDA-990-f photo-diode-array integration software.
High performance liquid chromatography
The HPLC was performed on a Bruker Model LC-31 Chromatograph equipped with Rheodyne injection valve (100 μΐ injection-loop), 20x4 mm RP-18 guard-column, 250 χ 4mm RP-18 analytical colum, both packed with LiChrosorb RP-18, 5 μπι material from Merck (Darmstadt, Germany). The guard column had to be replaced every 30 injections to avoid significant reduction of the separation properties.
UV-detection was performed with a photo-diode-array-detector (Millipore-Waters PDA-990+) using the following settings: wavelength range 200-400 nm, resolution 2nm, 1 scan per second, 27 ms sampling time; 27 sampling times were averaged per scan; sensitivity was set to high (7 points).
The eluents used were: The flow-rate was 1 ml/min, corresponding to a back-pressure of 130-145 bar.
Procedures and measurements
Preparation of the stock-standards
The final standard concentration for all substances was 500 μηιοΐ/ΐ. Allantoin, creatinine, inosine-S'-phosphate, orotic acid
Preparation of the serum samples
A serum sample (100 μΐ) was mixed with 400 μΐ of solvent C, then filtered through a membrane filter with a pore diameter of 0.22 μπι (Millipore GmbH, Eschborn, Germany). An aliquot (50 μΐ) of the filtrate was directly injected into the rheodyne injector of the HPLC device. The quantification of hypoxanthine, xanthine and uric acid is based on the peak areas calr culated for the wavelength described in the previous section.
Determination of allantoin
Allantoin was determined with a method according to Grootveld (8) with minor modifications. Serum samples and standards were treated in the same way. The fraction between elution time to of the void volume and to + 2 min was collected and evaporated under a nitrogen stream at 60 °C. The residue was reconstituted in 250 μΐ 0.12 mol/1 NaOH and incubated for 20 min at 100 °C. In this step allantoin is hydrolysed to allantoic acid. After adding 250 μΐ l mol/1 HC1 the mixture was incubated for 5 min at 100 0 C. This step hydrolyses allantoic to giyoxylic acid. Finally 25 μΐ 3 mmol/1 2,4-dinitrophenylhydraziniumhydrochloride in l mol/1 HC1 was added and the mixture incubated for 5 min at 100 °C. To enhance the precision of the determination, the final incubation mixture was evaporated to dryness under a nitrogen stream at 60 °C The residue was dissolved in 250 μΐ solvent D and 50 μΐ were injected into the HPLC-apparatus for isocratic rechromatography with solvent D, using the same column as before. The detection was performed at a wavelength of 360 nm.
Solvent system optimization
The eluent optimization was performed for pH values between 2.50 and 7.50 and for phosphate ion concentrations between 20 mmol/1 and 100 mmol/i. At every pH the retention times of Eur. J. Clin. Chem, Clin. Biochem. / Vol. 31,1993 / No. 5 the components allantoin, allopurinol, creatinine, hypoxanthine, inosine-5'-phosphate, orotic acid, oxipurinol, thymine, uridine, xanthine, uric acid were measured five times.
For calculation of the optimized eluent Composition the treatment described by Glajch (1980) was used. The chromalographic-response-function (CRF) has the general form:
where Pi = f/g is a measure of resolution of a pair of adjacent peaks;
f is the vertical distance of the valley-point between the two peaks and the line connecting the two peak maxima;
g is the vertical distance of the baseline to the line connecting the two peaks. If there is baseline-separation, f is equal to g and this results in Pj = 1 or In pi,· = 0;
PO is the desired peak separation and it is taken as 1 in this solvent system optimization.
The second expression contains t M , the maximum acceptable analysis time for one Chromatographie run; t L , the actual analysis time and a, an arbitrary weighting factor.
For simplification of the calculation presented here, the second expression is ignored. Only the separation of uric acid at a wavelength of 285 nm, hypoxanthine at 248 nm and xanthine at 264 nm from their adjacent peaks is of interest and needs to be considered. The function CRF defined in this way has an absolute extremum of CRF = 0 only when all substances of interest are baseline-separated from their neighbouring peaks. It is necessary to find one local extremum describing the solvent composition for the best separation of hypoxanthine, xanthine and uric acid from their neighbouring peaks.
The function CRF is then plotted as a function of pH and phosphate concentration c. The two variables of the elution system and the hyperplane should be described by a polynomial dependence of CRF (called z) on pH (called x) and c (called x):
The results found for the Chromatographie response function have to be fitted according to equation 2 with a method for a constrained multidimensional nonlinear-least-square fit (10) using the constraint z g 0. Finally the result for the pH and the phosphate concentration yielding the best separation is found from the total differential of CRF, as the highest local maximum of this function in the range 2.5 ^ pH < 7.5 and 20 mmol/l <, c < 100 mmol/l.
Results
Solvent optimization for the determination of uric acid, hypoxanthine, xanthine and allantoin
The results for the determination of the Chromatographie response function for the separation of uric acid, hypoxanthine and xanthine from the neighbouring peaks are shown in figure 1 . The optimization converged and the local maximum of the function CRF was found at a solvent pH of 4.65 and a phosphate ion concentration of 47 mmol/l. The calculated value at this eluent composition was CRF = -0.36. All following data were obtained with this eluent system and the CRF calculated from a chromatogram of a standard mixture ( fig. 2 ) was CRF = -0.39 + 0.02 (x + s). Due to the tailing of the peaks a full baseline separation could not be obtained with this Chromatographie system, but due to the relative concentrations of uric acid, hypoxanthine, uridine, and xanthine in serum this was satisfactory for all serum samples analysed. A chromatogram of a serum sample drawn from a healthy male adult is shown in figure 3 .
Imprecision data for the determination of hypoxanthine and xanthine Table 1 shows the data for the within-run imprecisions and the day-to-day imprecisions for serum samples supplemented with hypoxanthine and xanthine standard to cover the measuring range of interest. For these measurements, 50 μΐ aliquots of fivefold dilutions of the standard-substituted pooled serum samples were injected. The lowest concentration of 0.3 μηιοΙ/1 hypoxanthine and xanthine corresponds to the itijection of 3 pmol analyte. Within-run imprecision for the concentration range considered was 1.9% -4.5% for hypoxanthine and 1.5%-4.7% for xan- thine. Due to the error introduced from the calibration, the day-to-day imprecision was 2.2 -5.0% for hypoxanthine and 2.7% -5.3% for xanthine.
Tab. 1. Imprecision data for the determination of hypoxanthine, xanthine and uric acid Analyte Imprecision within-run (n = 20) Imprecision day-to-day (n = 20) Recovery data for hypoxanthine and xanthine Table 2 shows the standard recoveries for hypoxanthine and xanthine. For these experiments 200 μΐ pooled serum, 200 μΐ standard of the concentration shown in table 2 and 600 μΐ eluent were mixed, and 50 μΐ of this dilution were injected. In the case of hypoxanthine recoveries ranged from 90.2% to 101.2% with standard deviations not different from the imprecisions found. For xanthine the situation is similar to that of hypoxanthine, with recoveries ranging from 97.9% to 107.3%.
Imprecision and inaccuracy of the uric acid determination
The imprecision of the uric acid determination was determined separately from 4 pooled serum samples (data shown in tab. 1); the within-run imprecision was 0.95%-1.34%, between-run 1.23%-1.45%. The inaccuracy, determined with the reference material, human serum SRM 909 (certified uric acid concentration 480 μπιοΙ/1), was 485 ± 6 μιηοΐ/ΐ (η = 20). Imprecision and recovery for the determination of allantoin Table 3 shows the data for the imprecision and recovery experiments for allantoin. Figure 4 shows the chromatogram of the glyoxylate-2,4-dinitrophenylhydrazone from a serum sample containing 20 μπιοΐ/ΐ allantoin. Pooled serum was substituted with an allantoin standard solution and diluted with eluent C to give a five-fold serum dilution; 50 μΐ of this dilution were subsequently analysed. The imprecision was 5.8%-11.7% within-run and 6.3%-13.6% day-today. The recoveries, determined in samples treated as described for hypoxanthine and xanthine, were 86.3% to 93.2%.
• r Reference ranges Table 4a shows the results for the reference ranges determined for hypoxanthine, xanthine, allantoin, table 4b the results for uric acid, and figure 5a-5d the corresponding reference-ranges for all women in For this solvent system one Chromatographie run takes 20 min and a sufficient separation is established for all compounds in the serum samples tested. Due to the dynamic measuring range of the photo-diodearray-detector, uric acid could be quantified from the same Chromatographie run as hypoxanthine and xanthine, whose concentrations are about 30 and 150 times lower, respectively. Neither normal sera nor pathological sera from patients caused any observable Chromatographie interference. The use of a guard column in the method presented eliminates the requirement for sample deproteinisation techniques like ultrafiltration or protein precipitation with for example trichloroacetic acid. In contrast to the procedure originally presented by Grootveld (8) , the determination of aliantoin presented here is not sensitive to unintentional evaporation of the incubation mixture, because the glyoxylic acid-2,4-dinitrophenylhydrazone is finally dried and reconstituted in a well defined volume of solvent.
For hypoxanthine a coefficient of variation between days (CV dd ) of 5.0% was found for an injection of 3 pmol substance. For 3 pmol injected xanthine a slightly higher CV dd of 5.3% was found; this is due to a broader elution band shape. The recoveries in the standard recovery experiments were 90 -110%, determined by means of standard additions covering the reference range. The much more complicated de- termination procedure for allantoin resulted in a CV dd of 13.6% when analysing a 8 pmol sample, and the recoveries found for allantoin were 86 -93%. The results for uric acid were comparable to those previously published for a HPLC procedure optimized for the determination of uric acid.
The reference ranges of hypoxanthine, xanthine and allantoin did not show a significant dependence on age or sex. Only uric acid showed the well established higher reference range for men and an increase of this reference range for men with age.
With the method presented, a sensitive simultaneous determination of the metabolites of terminal purine metabolism, hypoxanthine, xanthine, uric acid and allantoin is possible. The method may also be used for other body fluids like urine and cerebrospinal fluid.
A paper is in preparation, in which we describe the changes of hypoxanthine, xanthine, uric acid and allantoin in patients with clincally well defined acute myocardial infarction in comparison with other diseases with muscle destruction.
